Börseninformationen

01.08.2024 07:07:02 - BUSINESS WIRE: AB InBev Reports Second Quarter 2024 Results

MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.

Consistent execution of our strategy delivered double-digit EBITDA growth with margin expansion of 236bps and a 25% increase in Underlying EPS

BRUSSELS --(BUSINESS WIRE)-- 01.08.2024 --

Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD):

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731260058/en/

Regulated information1

“Our global momentum continued this quarter. The strength of our diversified footprint and consumer demand for our megabrands delivered another quarter of broad-based top- and bottom-line growth. EBITDA grew by double-digits and the continued optimization of our business drove a 25% increase in Underlying EPS. We are encouraged with our performance in the first half of the year and remain focused on consistent execution of our strategy.” – Michel Doukeris, CEO, AB InBev

Total Revenue

+ 2.7%

Revenue increased by 2.7% in 2Q24 with revenue per hl growth of 3.6% and by 2.7% in HY24 with revenue per hl growth of 3.5%.

 

3.3% increase in combined revenues of our megabrands, led by Corona, which grew by 5.6% outside of its home market in 2Q24.

 

Approximately 70% of our revenue is through B2B digital platforms with the monthly active user base of BEES reaching 3.8 million users in 2Q24.

 

Approximately 140 million USD of revenue generated by our digital direct-to-consumer ecosystem in 2Q24.

 

Total Volume

- 0.8%

In 2Q24, total volumes declined by 0.8%, with own beer volumes down by 1.3% and non-beer volumes up by 3.4%.

In HY24, total volumes declined by 0.7% with own beer volumes down by 1.3% and non-beer volumes up by 3.5%.

 

Normalized EBITDA

+ 10.2%

In 2Q24, normalized EBITDA increased by 10.2% to 5 302 million USD with a normalized EBITDA margin expansion of 236bps to 34.6%.

In HY24, normalized EBITDA increased by 7.8% to 10 288 million USD with a normalized EBITDA margin expansion of 165bps to 34.4%.

 

Underlying Profit

1 811 million USD

Underlying profit (profit attributable to equity holders of AB InBev excluding non-underlying items and the impact of hyperinflation) was 1 811 million USD in 2Q24 compared to 1 452 million USD in 2Q23 and was 3 320 million USD in HY24 compared to 2 762 million USD in HY23.

 

Underlying EPS

0.90 USD

Underlying EPS was 0.90 USD in 2Q24, an increase from 0.72 USD in 2Q23 and was 1.66 USD in HY24, an increase from 1.37 USD in HY23.

 

 

Net Debt to EBITDA

3.42x

Net debt to normalized EBITDA ratio was 3.42x at 30 June 2024 compared to 3.70x at 30 June 2023 and 3.38x at 31 December 2023.

The 2024 Half Year Financial Report is available on our website at www.ab-inbev.com

1The enclosed information constitutes regulated information as defined in the Belgian Royal Decree of 14 November 2007 regarding the duties of issuers of financial instruments which have been admitted for trading on a regulated market. For important disclaimers and notes on the basis of preparation, please refer to page 16.

Management comments

Consistent execution of our strategy delivered double-digit EBITDA growth with margin expansion of 236bps and a 25% increase in Underlying EPS

Top-line increased by 2.7%, with revenue growth in approximately 65% of our markets, driven by a revenue per hl increase of 3.6% as a result of revenue management initiatives. Volume growth in our Middle Americas, South America, Europe and Africa regions was primarily offset by performance in China and Argentina, resulting in an overall volume decline of 0.8%. EBITDA increased by 10.2% with production cost efficiencies and disciplined overhead management driving EBITDA margin expansion of 236bps. Underlying EPS was 0.90 USD, a 25% increase versus 2Q23, driven primarily by nominal EBITDA growth.

Progressing our strategic priorities

We continue to execute on and invest in three key strategic pillars to deliver consistent growth and long-term value creation.

(1) Lead and grow the category:

We delivered volume growth in 50% of our markets in 2Q24 and gained market share in the majority in HY24, according to our estimates.

(2) Digitize and monetize our ecosystem:

BEES captured 11.7 billion USD of gross merchandise value (GMV), a 20% increase versus 2Q23 with approximately 70% of our revenue through B2B digital channels. BEES Marketplace captured 530 million USD in GMV from sales of third-party products, a 55% increase versus 2Q23.

(3) Optimize our business:

We continue to make progress on deleveraging with net debt to EBITDA reaching 3.42x as of 30 June 2024 versus 3.70x as of 30 June 2023. In HY24, we invested 5.3 billion USD in capex and sales and marketing while delivering free cash flow of approximately 0.9 billion USD, a 1.4 billion USD improvement versus HY23.

(1) Lead and grow the category

We continued to invest in our megabrands, mega platforms and brand building capabilities this quarter. According to the Kantar BrandZ 2024 report, our portfolio now holds 8 of the top 10 most valuable beer brands in the world, with Corona and Budweiser #1 and #2 respectively. Our marketing effectiveness and creativity were recognized by again being named the most effective marketer in the world by both Effies and the World Advertising Research Center and being the most awarded beverage company at the 2024 Cannes Lions International Festival of Creativity. Our performance across each of our 5 category expansion levers was led by our megabrands which delivered continued volume growth and a 3.3% revenue increase in 2Q24.

(2) Digitize and monetize our ecosystem

(3) Optimize our business

Creating a future with more cheers

In the first half of this year, our business delivered EBITDA growth of 7.8% with margin expansion of 165bps, while we continued to invest for the long-term in our brands, facilities and digital initiatives. Our nominal EBITDA growth and the continued optimization of our business drove strong operating leverage, resulting in an Underlying EPS increase of 21% in HY24. Our performance is made possible by the dedication and hard work of our people and we take this opportunity to thank all our colleagues globally for their passion and commitment. The beer category is large and growing, and our unique global leadership advantages, replicable growth drivers and superior profitability position us well to deliver on our purpose to create a future with more cheers.

2024 Outlook

  1. Overall Performance: We expect our EBITDA to grow in line with our medium-term outlook of between 4-8%. The outlook for FY24 reflects our current assessment of inflation and other macroeconomic conditions.
  2. Net Finance Costs: Net pension interest expenses and accretion expenses are expected to be in the range of 220 to 250 million USD per quarter, depending on currency and interest rate fluctuations. We expect the average gross debt coupon in FY24 to be approximately 4%.
  3. Effective Tax Rates (ETR): We expect the normalized ETR in FY24 to be in the range of 27% to 29%. The ETR outlook does not consider the impact of potential future changes in legislation.
  4. Net Capital Expenditure: We expect net capital expenditure of between 4.0 and 4.5 billion USD in FY24.

Figure 1. Consolidated performance (million USD)

2Q23

2Q24

Organic

growth

Total Volumes (thousand hls)

147 583

146 302

-0.8%

AB InBev own beer

128 750

126 926

-1.3%

Non-beer volumes

17 636

18 235

3.4%

Third party products

1 197

1 140

-4.7%

Revenue

15 120

15 333

2.7%

Gross profit

8 101

8 567

7.0%

Gross margin

53.6%

55.9%

224bps

Normalized EBITDA

4 909

5 302

10.2%

Normalized EBITDA margin

32.5%

34.6%

236bps

Normalized EBIT

3 569

3 905

11.9%

Normalized EBIT margin

23.6%

25.5%

209bps

 

Profit attributable to equity holders of AB InBev

339

1 472

Underlying profit attributable to equity holders of AB InBev

1 452

1 811

 

Earnings per share (USD)

0.17

0.73

Underlying earnings per share (USD)

0.72

0.90

 

 

HY23

HY24

Organic

growth

Total Volumes (thousand hls)

288 131

285 837

-0.7%

AB InBev own beer

249 810

246 313

-1.3%

Non-beer volumes

36 223

37 465

3.5%

Third party products

2 098

2 059

-1.8%

Revenue

29 333

29 880

2.7%

Gross profit

15 796

16 461

4.9%

Gross margin

53.9%

55.1%

117bps

Normalized EBITDA

9 668

10 288

7.8%

Normalized EBITDA margin

33.0%

34.4%

165bps

Normalized EBIT

7 072

7 547

8.5%

Normalized EBIT margin

24.1%

25.3%

135bps

 

Profit attributable to equity holders of AB InBev

1 977

2 564

Underlying profit attributable to equity holders of AB InBev

2 762

3 320

 

Earnings per share (USD)

0.98

1.28

Underlying earnings per share (USD)

1.37

1.66

 

 

Figure 2. Volumes (thousand hls)

2Q23

Scope

Organic

2Q24

Organic growth

growth

Total

Own beer

North America

23 542

-156

- 747

22 639

-3.2%

-3.9%

Middle Americas

37 893

-4

493

38 381

1.3%

1.8%

South America

35 737

-

232

35 969

0.6%

-0.9%

EMEA

22 884

-

968

23 852

4.2%

3.8%

Asia Pacific

27 475

-

-2 076

25 399

-7.6%

-7.6%

Global Export and Holding Companies

51

-

11

62

21.2%

-

AB InBev Worldwide

147 583

- 161

-1 121

146 302

-0.8%

-1.3%

 

HY23

Scope

Organic

HY24

Organic growth

growth

Total

Own beer

North America

47 395

-311

-3 092

43 992

-6.6%

-7.5%

Middle Americas

72 164

-9

1 916

74 072

2.7%

3.0%

South America

76 023

-

292

76 315

0.4%

-0.8%

EMEA

42 842

-

2 040

44 882

4.8%

4.3%

Asia Pacific

49 589

-

-3 145

46 444

-6.3%

-6.3%

Global Export and Holding Companies

117

-

15

132

12.5%

-

AB InBev Worldwide

288 131

- 320

-1 973

285 837

-0.7%

-1.3%

 

Key Market Performances

United States: Improved market share trend, ongoing premiumization and productivity initiatives deliver double-digit bottom-line growth

Mexico: Mid-single digit top-line and double-digit bottom-line growth with margin expansion

Colombia: Record high volumes delivered double-digit top- and bottom-line growth with margin expansion

Brazil: Record high volumes delivered high-single digit top-line and double-digit bottom-line growth with margin expansion

Europe: High-single digit bottom-line growth with margin recovery

South Africa: Record high volumes delivered double digit top- and bottom-line growth with margin expansion

China: Revenue declined by double-digits, impacted by soft industry

Highlights from our other markets

Consolidated Income Statement

Figure 3. Consolidated income statement (million USD)

2Q23

2Q24

Organic

growth

Revenue

15 120

15 333

2.7%

Cost of sales

-7 019

-6 766

2.2%

Gross profit

8 101

8 567

7.0%

SG&A

-4 707

-4 813

-2.3%

Other operating income/(expenses)

175

151

-20.8%

Normalized profit from operations (normalized EBIT)

3 569

3 905

11.9%

Non-underlying items above EBIT (incl. impairment losses)

-60

-90

Net finance income/(cost)

-1 283

-1 170

Non-underlying net finance income/(cost)

-1 078

- 221

Share of results of associates

55

79

Income tax expense

-595

-752

Profit

607

1 751

Profit attributable to non-controlling interest

269

279

Profit attributable to equity holders of AB InBev

339

1 472

 

Normalized EBITDA

4 909

5 302

10.2%

Underlying profit attributable to equity holders of AB InBev

1 452

1 811

.

HY23

HY24

Organic

growth

Revenue

29 333

29 880

2.7%

Cost of sales

-13 536

-13 419

-0.1%

Gross profit

15 796

16 461

4.9%

SG&A

-9 051

-9 248

-1.9%

Other operating income/(expenses)

327

334

-2.7%

Normalized profit from operations (normalized EBIT)

7 072

7 547

8.5%

Non-underlying items above EBIT (incl. impairment losses)

-107

-119

Net finance income/(cost)

-2 520

-2 357

Non-underlying net finance income/(cost)

-703

-530

Share of results of associates

105

137

Non-underlying share of results of associates

-

104

Income tax expense

-1 192

-1 546

Profit

2 655

3 236

Profit attributable to non-controlling interest

678

672

Profit attributable to equity holders of AB InBev

1 977

2 564

 

Normalized EBITDA

9 668

10 288

7.8%

Underlying profit attributable to equity holders of AB InBev

2 762

3 320

.

 

Non-underlying items above EBIT & Non-underlying share of results of associates

Figure 4. Non-underlying items above EBIT & Non-underlying share of results of associates (million USD)

2Q23

2Q24

HY23

HY24

Restructuring

-22

-28

-50

-59

Business and asset disposal (incl. impairment losses)

-19

-62

-38

-60

Claims and legal costs

-19

-

-19

-

Non-underlying items in EBIT

-60

-90

-107

-119

Non-underlying share of results of associates

-

-

-

104

 

Non-underlying share of results from associates of HY24 includes the impact from our associate Anadolu Efes’ adoption of IAS 29 hyperinflation accounting on their 2023 results.

Net finance income/(cost)

Figure 5. Net finance income/(cost) (million USD)

2Q23

2Q24

HY23

HY24

Net interest expense

-824

-746

-1 630

-1 460

Net interest on net defined benefit liabilities

-21

-23

-42

-45

Accretion expense

-202

-191

-385

-382

Net interest income on Brazilian tax credits

47

25

78

61

Other financial results

-283

-235

-540

-530

Net finance income/(cost)

-1 283

-1 170

-2 520

-2 357

 

Non-underlying net finance income/(cost)

Figure 6. Non-underlying net finance income/(cost) (million USD)

2Q23

2Q24

HY23

HY24

Mark-to-market

-1 078

-264

-703

-507

Gain/(loss) on bond redemption and other

-

43

-

-23

Non-underlying net finance income/(cost)

-1 078

-221

-703

-530

 

Non-underlying net finance cost in HY24 includes mark-to-market losses on derivative instruments entered into in order to hedge our share-based payment programs and shares issued in relation to the combination with Grupo Modelo and SAB, and a 43 million USD gain related to the completion of tender offers of notes issued by the company and certain of its subsidiaries.

The number of shares covered by the hedging of our share-based payment program, the deferred share instrument and the restricted shares are shown in figure 7, together with the opening and closing share prices.

Figure 7. Non-underlying equity derivative instruments

2Q23

2Q24

HY23

HY24

Share price at the start of the period (Euro)

61.33

56.46

56.27

58.42

Share price at the end of the period (Euro)

51.83

54.12

51.83

54.12

Number of equity derivative instruments at the end of the period (millions)

100.5

100.5

100.5

100.5

 

Income tax expense

Figure 8. Income tax expense (million USD)

2Q23

2Q24

HY23

HY24

Income tax expense

595

752

1 192

1 546

Effective tax rate

51.9%

31.0%

31.9%

34.1%

Normalized effective tax rate

27.8%

27.4%

27.3%

27.2%

 

The 2Q23 and 2Q24 effective tax rates were negatively impacted by non-deductible losses from derivatives related to the hedging of share-based payment programs and of the shares issued in a transaction related to the combination with Grupo Modelo and SAB.

Furthermore, the HY24 effective tax rate includes 133 million USD of non-underlying tax expenses, reflecting mainly the impact of a 240 million USD (4.5 billion ZAR) non-underlying tax cost following the resolution of the South African tax matters as described in note 21 Contingencies of the HY24 Unaudited Interim Report and the release of tax provisions.

Figure 9. Underlying Profit attributable to equity holders of AB InBev (million USD)

2Q23

2Q24

HY23

HY24

Profit attributable to equity holders of AB InBev

339

1 472

1 977

2 564

Net impact of non-underlying items on profit

1 092

313

750

675

Hyperinflation impacts in underlying profit

22

26

35

81

Underlying profit attributable to equity holders of AB InBev

1 452

1 811

2 762

3 320

 

Basic and underlying EPS

Figure 10. Earnings per share (USD)

2Q23

2Q24

HY23

HY24

Basic EPS

0.17

0.73

0.98

1.28

Net impact of non-underlying items on profit

0.53

0.16

0.36

0.34

Hyperinflation impacts in EPS

0.01

0.01

0.02

0.04

Underlying EPS

0.72

0.90

1.37

1.66

Weighted average number of ordinary and restricted shares (million)

2 016

2 005

2 016

2 005

 

Figure 11. Key components - Underlying EPS in USD

2Q23

2Q24

HY23

HY24

Normalized EBIT before hyperinflation

1.78

1.96

3.54

3.78

Hyperinflation impacts in normalized EBIT

-0.01

-0.01

-0.03

-0.02

Normalized EBIT

1.77

1.95

3.51

3.76

Net finance cost

-0.64

-0.58

-1.25

-1.18

Income tax expense

-0.31

-0.37

-0.62

-0.70

Associates & non-controlling interest

-0.11

-0.10

-0.29

-0.27

Hyperinflation impacts in EPS

0.01

0.01

0.02

0.04

Underlying EPS

0.72

0.90

1.37

1.66

Weighted average number of ordinary and restricted shares (million)

2 016

2 005

2 016

2 005

 

Reconciliation between normalized EBITDA and profit attributable to equity holders

Figure 12. Reconciliation of normalized EBITDA to profit attributable to equity holders of AB InBev (million USD)

2Q23

2Q24

HY23

HY24

Profit attributable to equity holders of AB InBev

339

1 472

1 977

2 564

Non-controlling interests

269

279

678

672

Profit

607

1 751

2 655

3 236

Income tax expense

595

752

1 192

1 546

Share of result of associates

-55

-79

-105

-137

Non-underlying share of results of associates

-

-

-

- 104

Net finance (income)/cost

1 283

1 170

2 520

2 357

Non-underlying net finance (income)/cost

1 078

221

703

530

Non-underlying items above EBIT (incl. impairment losses)

60

90

107

119

Normalized EBIT

3 569

3 905

7 072

7 547

Depreciation, amortization and impairment

1 340

1 397

2 596

2 741

Normalized EBITDA

4 909

5 302

9 668

10 288

 

Normalized EBITDA and normalized EBIT are measures utilized by AB InBev to demonstrate the company’s underlying performance.

Normalized EBITDA is calculated excluding the following effects from profit attributable to equity holders of AB InBev: (i) non-controlling interest; (ii) income tax expense; (iii) share of results of associates; (iv) non-underlying share of results of associates; (v) net finance income or cost; (vi) non-underlying net finance income or cost; (vii) non-underlying items above EBIT; and (viii) depreciation, amortization and impairment.

Normalized EBITDA and normalized EBIT are not accounting measures under IFRS and should not be considered as an alternative to profit attributable to equity holders as a measure of operational performance, or an alternative to cash flow as a measure of liquidity. Normalized EBITDA and normalized EBIT do not have a standard calculation method and AB InBev’s definition of normalized EBITDA and normalized EBIT may not be comparable to that of other companies.

Financial position

Figure 13. Cash Flow Statement (million USD)

HY23

HY24

Operating activities

Profit of the period

2 655

3 236

Interest, taxes and non-cash items included in profit

7 512

7 588

Cash flow from operating activities before changes in working capital and use of provisions

10 167

10 824

 

Change in working capital

-4 615

-4 170

Pension contributions and use of provisions

- 192

- 251

Interest and taxes (paid)/received

-3 806

-3 958

Dividends received

43

123

Cash flow from/(used in) operating activities

1 597

2 568

 

Investing activities

Net capex

-2 063

-1 684

Sale/(acquisition) of subsidiaries, net of cash disposed/ acquired of

- 8

- 19

Net proceeds from sale/(acquisition) of other assets

- 18

- 29

Cash flow from/(used in) investing activities

-2 089

-1 732

 

Financing activities

Net (repayments of) / proceeds from borrowings

155

1 124

Dividends paid

-1 923

-2 142

Share buyback

-

- 838

Payment of lease liabilities

- 359

- 406

Derivative financial instruments

- 360

- 172

Sale/(acquisition) of non-controlling interests

- 3

- 414

Other financing cash flows

- 304

- 465

Cash flow from/(used in) financing activities

-2 795

-3 313

.

Net increase/(decrease) in cash and cash equivalents

-3 287

-2 476

 

HY24 recorded a decrease in cash and cash equivalents of 2 476 million USD compared to a decrease of 3 287 million USD in HY23, with the following movements:

Our net debt increased to 70.4 billion USD as of 30 June 2024 from 67.6 billion USD as of 31 December 2023.

Our net debt to normalized EBITDA ratio was 3.42x as of 30 June 2024. Our optimal capital structure is a net debt to normalized EBITDA ratio of around 2x.

We continue to proactively manage our debt portfolio. 99% of our bond portfolio holds a fixed-interest rate, 43% is denominated in currencies other than USD and maturities are well-distributed across the next several years.

As of 30 June 2024, we had total liquidity of 17.7 billion USD, which consisted of 10.1 billion USD available under committed long-term credit facilities and 7.6 billion USD of cash, cash equivalents and short-term investments in debt securities less bank overdrafts.

Notes

To facilitate the understanding of AB InBev’s underlying performance, the analyses of growth, including all comments in this press release, unless otherwise indicated, are based on organic growth and normalized numbers. In other words, financials are analyzed eliminating the impact of changes in currencies on translation of foreign operations, and scope changes. For FY24, the definition of organic revenue growth has been amended to cap the price growth in Argentina to a maximum of 2% per month (26.8% year-over-year). Corresponding adjustments are made to all income statement related items in the organic growth calculations through scope changes. Scope changes also represent the impact of acquisitions and divestitures, the start or termination of activities or the transfer of activities between segments, curtailment gains and losses and year over year changes in accounting estimates and other assumptions that management does not consider as part of the underlying performance of the business. The organic growth of our global brands, Budweiser, Stella Artois, Corona and Michelob Ultra, excludes exports to Australia for which a perpetual license was granted to a third party upon disposal of the Australia operations in 2020. All references per hectoliter (per hl) exclude US non-beer activities. Whenever presented in this document, all performance measures (EBITDA, EBIT, profit, tax rate, EPS) are presented on a “normalized” basis, which means they are presented before non-underlying items. Non-underlying items are either income or expenses which do not occur regularly as part of the normal activities of the Company. They are presented separately because they are important for the understanding of the underlying sustainable performance of the Company due to their size or nature. Normalized measures are additional measures used by management and should not replace the measures determined in accordance with IFRS as an indicator of the Company’s performance. We are reporting the results from Argentina applying hyperinflation accounting since 3Q18. The IFRS rules (IAS 29) require us to restate the year-to-date results for the change in the general purchasing power of the local currency, using official indices before converting the local amounts at the closing rate of the period. In HY24, we reported a negative impact from hyperinflation accounting on the profit attributable to equity holders of AB InBev of 81 million USD. The impact in HY24 Basic EPS was -0.04 USD. Values in the figures and annexes may not add up, due to rounding. 2Q24 and HY24 EPS is based upon a weighted average of 2 005 million shares compared to a weighted average of 2 016 million shares for 2Q23 and HY23.

Legal disclaimer

This release contains “forward-looking statements”. These statements are based on the current expectations and views of future events and developments of the management of AB InBev and are naturally subject to uncertainty and changes in circumstances. The forward-looking statements contained in this release include statements other than historical facts and include statements typically containing words such as “will”, “may”, “should”, “believe”, “intends”, “expects”, “anticipates”, “targets”, “estimates”, “likely”, “foresees” and words of similar import. All statements other than statements of historical facts are forward-looking statements. You should not place undue reliance on these forward-looking statements, which reflect the current views of the management of AB InBev, are subject to numerous risks and uncertainties about AB InBev and are dependent on many factors, some of which are outside of AB InBev’s control. There are important factors, risks and uncertainties that could cause actual outcomes and results to be materially different, including, but not limited to the risks and uncertainties relating to AB InBev that are described under Item 3.D of AB InBev’s Annual Report on Form 20-F filed with the SEC on 11 March 2024. Many of these risks and uncertainties are, and will be, exacerbated by any further worsening of the global business and economic environment, including as a result of the ongoing conflict in Russia and Ukraine and in the Middle East, including the conflict in the Red Sea. Other unknown or unpredictable factors could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statements should be read in conjunction with the other cautionary statements that are included elsewhere, including AB InBev’s most recent Form 20-F and other reports furnished on Form 6-K, and any other documents that AB InBev has made public. Any forward-looking statements made in this communication are qualified in their entirety by these cautionary statements and there can be no assurance that the actual results or developments anticipated by AB InBev will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, AB InBev or its business or operations. Except as required by law, AB InBev undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The second quarter 2024 (2Q24) and half year 2024 (HY24) financial data set out in Figure 1 (except for the volume information), Figures 3 to 5, 6, 8, 9, 12 and 13 of this press release have been extracted from the group’s unaudited condensed consolidated interim financial statements as of and for the six months ended 30 June 2024, which have been reviewed by our statutory auditors PwC Réviseurs d’Entreprises SRL / PwC Bedrijfsrevisoren BV in accordance with the standards of the Public Company Accounting Oversight Board (United States). Financial data included in Figures 7, 10, 11 and 14 have been extracted from the underlying accounting records as of and for the six months ended 30 June 2024 (except for the volume information). References in this document to materials on our websites, such as www.ab-inbev.com, are included as an aid to their location and are not incorporated by reference into this document.

Conference call and webcast

Investor Conference call and webcast on Thursday, 1 August 2024:
1.00pm Brussels / 12.00pm London / 7.00am New York

Registration details:
Webcast (listen-only mode):
AB InBev 2Q24 Results Webcast

To join by phone, please use one of the following two phone numbers:
Toll-Free: +1-877-407-8029
Toll: +1-201-689-8029

About AB InBev

Anheuser-Busch InBev (AB InBev) is a publicly traded company (Euronext: ABI) based in Leuven, Belgium, with secondary listings on the Mexico (MEXBOL: ANB) and South Africa (JSE: ANH) stock exchanges and with American Depositary Receipts on the New York Stock Exchange (NYSE: BUD). As a company, we dream big to create a future with more cheers. We are always looking to serve up new ways to meet life’s moments, move our industry forward and make a meaningful impact in the world. We are committed to building great brands that stand the test of time and to brewing the best beers using the finest ingredients. Our diverse portfolio of well over 500 beer brands includes global brands Budweiser®, Corona®, Stella Artois® and Michelob Ultra®; multi-country brands Beck’s®, Hoegaarden® and Leffe®; and local champions such as Aguila®, Antarctica®, Bud Light®, Brahma®, Cass®, Castle®, Castle Lite®, Cristal®, Harbin®, Jupiler®, Modelo Especial®, Quilmes®, Victoria®, Sedrin®, and Skol®. Our brewing heritage dates back more than 600 years, spanning continents and generations. From our European roots at the Den Hoorn brewery in Leuven, Belgium. To the pioneering spirit of the Anheuser & Co brewery in St. Louis, US. To the creation of the Castle Brewery in South Africa during the Johannesburg gold rush. To Bohemia, the first brewery in Brazil. Geographically diversified with a balanced exposure to developed and developing markets, we leverage the collective strengths of approximately 155,000 colleagues based in nearly 50 countries worldwide. For 2023, AB InBev’s reported revenue was 59.4 billion USD (excluding JVs and associates).

Annex 1: Segment reporting (2Q)

AB InBev Worldwide

2Q23

Scope

Currency

Translation

Organic

Growth

2Q24

Organic

Growth

Total volumes (thousand hls)

147 583

-161

-

-1 121

146 302

-0.8%

of which AB InBev own beer

128 750

-155

-

-1 669

126 926

-1.3%

Revenue

15 120

422

-622

413

15 333

2.7%

Cost of sales

-7 019

-395

493

155

-6 766

2.2%

Gross profit

8 101

27

-128

568

8 567

7.0%

SG&A

-4 707

-283

286

-108

-4 813

-2.3%

Other operating income/(expenses)

175

12

2

-38

151

-20.8%

Normalized EBIT

3 569

-244

159

421

3 905

11.9%

Normalized EBITDA

4 909

-173

67

499

5 302

10.2%

Normalized EBITDA margin

32.5%

34.6%

236bps

 

North America

2Q23

Scope

Currency

Translation

Organic

Growth

2Q24

Organic

Growth

Total volumes (thousand hls)

23 542

-156

-

-747

22 639

-3.2%

Revenue

3 953

-38

-1

-51

3 864

-1.3%

Cost of sales

-1 745

22

-

117

-1 606

6.8%

Gross profit

2 208

-16

-

66

2 258

3.0%

SG&A

-1 215

4

-

110

-1 101

9.1%

Other operating income/(expenses)

10

-

-

-6

4

-

Normalized EBIT

1 003

-12

-

169

1 161

17.1%

Normalized EBITDA

1 189

-13

-

162

1 338

13.8%

Normalized EBITDA margin

30.1%

34.6%

458bps

 

Middle Americas

2Q23

Scope

Currency

Translation

Organic

Growth

2Q24

Organic

Growth

Total volumes (thousand hls)

37 893

-4

-

493

38 381

1.3%

Revenue

4 084

-7

205

240

4 522

5.9%

Cost of sales

-1 571

-6

-67

51

-1 593

3.2%

Gross profit

2 513

-13

138

292

2 929

11.7%

SG&A

-985

-

-51

-64

-1 100

-6.5%

Other operating income/(expenses)

10

6

1

-5

11

-

Normalized EBIT

1 538

-8

88

223

1 841

14.5%

Normalized EBITDA

1 916

-7

104

206

2 219

10.8%

Normalized EBITDA margin

46.9%

49.1%

215bps

 

South America

2Q23

Scope

Currency

Translation

Organic

Growth

2Q24

Organic

Growth

Total volumes (thousand hls)

35 737

-

-

232

35 969

0.6%

Revenue

2 742

463

-588

168

2 785

6.1%

Cost of sales

-1 423

-401

424

-27

-1 427

-1.9%

Gross profit

1 319

63

-164

141

1 359

10.5%

SG&A

-926

-311

285

-24

-976

-2.4%

Other operating income/(expenses)

81

4

-5

19

99

22.7%

Normalized EBIT

475

-244

115

136

482

30.2%

Normalized EBITDA

737

-172

31

154

750

21.7%

Normalized EBITDA margin

26.9%

26.9%

380bps

EMEA

2Q23

Scope

Currency

Translation

Organic

Growth

2Q24

Organic

Growth

Total volumes (thousand hls)

22 884

-

-

968

23 852

4.2%

Revenue

2 248

5

-177

226

2 301

10.0%

Cost of sales

-1 207

-4

122

-89

-1 179

-7.4%

Gross profit

1 041

-

-56

137

1 122

13.1%

SG&A

-662

-6

34

-57

-691

-8.6%

Other operating income/(expenses)

47

1

-

-14

34

-28.3%

Normalized EBIT

426

-5

-22

66

465

15.6%

Normalized EBITDA

680

-5

-40

86

721

12.7%

Normalized EBITDA margin

30.3%

31.3%

73bps

 

Asia Pacific

2Q23

Scope

Currency

Translation

Organic

Growth

2Q24

Organic

Growth

Total volumes (thousand hls)

27 475

-

-

-2 076

25 399

-7.6%

Revenue

1 973

-1

-61

-163

1 749

-8.2%

Cost of sales

-927

-6

27

85

-821

9.1%

Gross profit

1 046

-7

-33

-77

928

-7.4%

SG&A

-584

-8

18

24

-549

4.1%

Other operating income/(expenses)

21

1

-1

10

30

44.7%

Normalized EBIT

483

-14

-16

-43

410

-9.2%

Normalized EBITDA

645

-15

-22

-38

570

-6.0%

Normalized EBITDA margin

32.7%

32.6%

78bps

 

Global Export and Holding Companies

2Q23

Scope

Currency

Translation

Organic

Growth

2Q24

Organic

Growth

Total volumes (thousand hls)

51

-

-

11

62

21.2%

Revenue

119

-

-

-8

112

-6.4%

Cost of sales

-147

-

-13

18

-141

12.1%

Gross profit

-27

-

-12

10

-30

37.2%

SG&A

-336

38

-1

-97

-396

-32.7%

Other operating income/(expenses)

7

-

7

-42

-28

-

Normalized EBIT

-357

38

-6

-129

-453

-40.4%

Normalized EBITDA

-257

38

-6

-70

-295

-32.1%

 

Annex 2: Segment reporting (HY)

AB InBev Worldwide

HY23

Scope

Currency

Translation

Organic

Growth

HY24

Organic

Growth

Total volumes (thousand hls)

288 131

- 320

-

-1 973

285 837

-0.7%

of which AB InBev own beer

249 810

- 304

-

-3 192

246 313

-1.3%

Revenue

29 333

1 732

-1 970

785

29 880

2.7%

Cost of sales

-13 536

-1 019

1 148

- 11

-13 419

-0.1%

Gross profit

15 796

712

- 822

774

16 461

4.9%

SG&A

-9 051

- 672

646

- 171

-9 248

-1.9%

Other operating income/(expenses)

327

11

5

-9

334

-2.7%

Normalized EBIT

7 072

51

- 170

594

7 547

8.5%

Normalized EBITDA

9 668

218

- 352

755

10 288

7.8%

Normalized EBITDA margin

33.0%

34.4%

165bps

 

North America

HY23

Scope

Currency

Translation

Organic

Growth

HY24

Organic

Growth

Total volumes (thousand hls)

47 395

- 311

-

-3 092

43 992

-6.6%

Revenue

7 926

- 75

1

- 396

7 457

-5.0%

Cost of sales

-3 420

42

- 1

228

-3 150

6.7%

Gross profit

4 506

- 32

1

- 169

4 307

-3.8%

SG&A

-2 354

21

- 1

147

-2 186

6.3%

Other operating income/(expenses)

18

-

-

-26

-8

-

Normalized EBIT

2 171

- 11

-

- 48

2 112

-2.2%

Normalized EBITDA

2 539

- 13

-

- 62

2 464

-2.5%

Normalized EBITDA margin

32.0%

33.0%

88bps

 

Middle Americas

HY23

Scope

Currency

Translation

Organic

Growth

HY24

Organic

Growth

Total volumes (thousand hls)

72 164

- 9

-

1 916

74 072

2.7%

Revenue

7 573

- 12

494

519

8 574

6.9%

Cost of sales

-2 926

- 13

- 182

- 58

-3 179

-2.0%

Gross profit

4 646

- 24

312

461

5 395

10.0%

SG&A

-1 863

4

- 122

- 84

-2 065

-4.5%

Other operating income/(expenses)

8

13

2

-

23

-

Normalized EBIT

2 792

- 8

192

377

3 353

13.5%

Normalized EBITDA

3 494

-

237

374

4 105

10.7%

Normalized EBITDA margin

46.1%

47.9%

166bps

 

South America

HY23

Scope

Currency

Translation

Organic

Growth

HY24

Organic

Growth

Total volumes (thousand hls)

76 023

-

-

292

76 315

0.4%

Revenue

5 849

1 813

-1 971

327

6 018

5.6%

Cost of sales

-2 949

-1 031

1 026

- 59

-3 013

-2.0%

Gross profit

2 900

782

- 944

267

3 005

9.1%

SG&A

-1 804

- 721

663

- 55

-1 917

-2.9%

Other operating income/(expenses)

171

-5

9

40

215

23.1%

Normalized EBIT

1 268

57

- 273

252

1 304

20.5%

Normalized EBITDA

1 766

220

- 449

298

1 834

17.3%

Normalized EBITDA margin

30.2%

30.5%

326bps

EMEA

HY23

Scope

Currency

Translation

Organic

Growth

HY24

Organic

Growth

Total volumes (thousand hls)

42 842

-

-

2 040

44 882

4.8%

Revenue

4 070

6

- 372

524

4 228

12.8%

Cost of sales

-2 210

- 6

249

- 247

-2 215

-11.2%

Gross profit

1 860

1

- 123

276

2 014

14.9%

SG&A

-1 307

- 7

70

- 61

-1 305

-4.7%

Other operating income/(expenses)

83

1

-3

-2

79

-2.6%

Normalized EBIT

635

-5

-56

213

787

33.8%

Normalized EBITDA

1 142

- 5

- 95

248

1 290

21.8%

Normalized EBITDA margin

28.1%

30.5%

221bps

 

Asia Pacific

HY23

Scope

Currency

Translation

Organic

Growth

HY24

Organic

Growth

Total volumes (thousand hls)

49 589

-

-

-3 145

46 444

-6.3%

Revenue

3 679

-1

-123

-171

3 383

-4.6%

Cost of sales

-1 750

-13

55

124

-1 583

7.0%

Gross profit

1 929

-14

-68

-47

1 800

-2.5%

SG&A

-1 033

-8

35

12

-994

1.2%

Other operating income/(expenses)

53

1

-2

4

56

8.0%

Normalized EBIT

949

-21

-36

-31

861

-3.3%

Normalized EBITDA

1 273

-22

-47

-17

1 186

-1.4%

Normalized EBITDA margin

34.6%

35.0%

116bps

 

Global Export and Holding Companies

HY23

Scope

Currency

Translation

Organic

Growth

HY24

Organic

Growth

Total volumes (thousand hls)

117

-

-

15

132

12.5%

Revenue

236

-

1

-16

221

-6.9%

Cost of sales

-281

-

-

2

-279

0.7%

Gross profit

-45

-

1

-14

-59

-

SG&A

-692

38

2

-129

-781

-19.7%

Other operating income/(expenses)

-6

-

-

-25

-31

-

Normalized EBIT

-742

38

2

-168

-870

-23.9%

Normalized EBITDA

-545

38

3

-86

-590

-16.9%

 

Annex 3: Consolidated statement of financial position

Million US dollar

30 June 2024

31 December 2023

 

ASSETS

Non-current assets

Property, plant and equipment

25 086

26 818

Goodwill

113 451

117 043

Intangible assets

40 703

41 286

Investments in associates

4 865

4 872

Investment securities

185

178

Deferred tax assets

2 771

2 935

Pensions and similar obligations

12

12

Income tax receivables

749

844

Derivatives

184

44

Trade and other receivables

1 687

1 941

Total non-current assets

189 694

195 973

 

Current assets

Investment securities

252

67

Inventories

5 567

5 583

Income tax receivables

611

822

Derivatives

448

505

Trade and other receivables

6 705

6 024

Cash and cash equivalents

7 392

10 332

Assets classified as held for sale

51

34

Total current assets

21 026

23 367

 

Total assets

210 720

219 340

 

EQUITY AND LIABILITIES

Equity

Issued capital

1 736

1 736

Share premium

17 620

17 620

Reserves

15 617

20 276

Retained earnings

43 543

42 215

Equity attributable to equity holders of AB InBev

78 517

81 848

 

Non-controlling interests

10 725

10 828

Total equity

89 241

92 676

 

Non-current liabilities

Interest-bearing loans and borrowings

75 944

74 163

Pensions and similar obligations

1 495

1 673

Deferred tax liabilities

11 761

11 874

Income tax payables

408

589

Derivatives

55

151

Trade and other payables

880

738

Provisions

368

320

Total non-current liabilities

90 912

89 508

 

Current liabilities

Bank overdrafts

17

17

Interest-bearing loans and borrowings

2 240

3 987

Income tax payables

1 144

1 583

Derivatives

5 223

5 318

Trade and other payables

21 708

25 981

Provisions

235

269

Total current liabilities

30 566

37 156

 

Total equity and liabilities

210 720

219 340

 

Annex 4: Consolidated statement of cash flows

For the six-month period ended 30 June

Million US dollar

2024

2023

.

OPERATING ACTIVITIES

Profit of the period

3 236

2 655

Depreciation, amortization and impairment

2 741

2 595

Net finance cost/(income)

2 887

3 223

Equity-settled share-based payment expense

315

286

Income tax expense

1 546

1 192

Other non-cash items

339

321

Share of result of associates

-241

-105

Cash flow from operating activities before changes in working capital and use of provisions

10 824

10 167

Decrease/(increase) in trade and other receivables

-1 154

-1 325

Decrease/(increase) in inventories

-325

-228

Increase/(decrease) in trade and other payables

-2 691

-3 062

Pension contributions and use of provisions

-251

-192

Cash generated from operations

6 403

5 360

Interest paid

-2 001

-2 322

Interest received

303

512

Dividends received

123

43

Income tax paid

-2 260

-1 996

Cash flow from/(used in) operating activities

2 568

1 597

.

INVESTING ACTIVITIES

Acquisition of property, plant and equipment and of intangible assets

-1 735

-2 107

Proceeds from sale of property, plant and equipment and of intangible assets

52

44

Sale/(acquisition) of subsidiaries, net of cash disposed/ acquired of

-19

-8

Proceeds from sale/(acquisition) of other assets

-29

-18

Cash flow from/(used in) investing activities

-1 732

-2 089

.

FINANCING ACTIVITIES

Proceeds from borrowings

5 466

181

Repayments of borrowings

-4 342

-26

Dividends paid

-2 142

-1 923

Share buyback

-838

-

Payment of lease liabilities

-406

-359

Derivative financial instruments

-172

-360

Sale/(acquisition) of non-controlling interests

-414

-3

Other financing cash flows

-465

-305

Cash flow from/(used in) financing activities

-3 313

-2 795

.

Net increase/(decrease) in cash and cash equivalents

-2 476

-3 287

Cash and cash equivalents less bank overdrafts at beginning of year

10 314

9 890

Effect of exchange rate fluctuations

-463

191

Cash and cash equivalents less bank overdrafts at end of period

7 375

6 794

 

Investors
Shaun Fullalove
E-mail: shaun.fullalove@ab-inbev.com

Ekaterina Baillie
E-mail: ekaterina.baillie@ab-inbev.com

Cyrus Nentin
E-mail: cyrus.nentin@ab-inbev.com

Media
Media Relations
E-mail: media.relations@ab-inbev.com

Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
ANHEUSER-BUSCH INBEV A2ASUV Frankfurt 48,160 23.12.24 11:08:02 +0,120 +0,25% 0,000 0,000 47,830 48,160

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen |
2024 Infront Financial Technology GmbH